When MRI offered no clear answer in suspected prostate cancer, the use of prostate-specific membrane antigen (PSMA)-PET/CT ...
Morning Overview on MSN
New prostate cancer immunotherapy cuts biomarkers by up to 99% in trial
A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced ...
It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential ...
The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...
AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.
"This technology gives us a powerful tool to detect prostate cancer earlier and more precisely,” said Dr. James Howard.
Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.
Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results